Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Stereoselective neurochemical, behavioral, and cardiovascular effects of α-pyrrolidinovalerophenone enantiomers in male rats.

Schindler CW, Thorndike EB, Walters HM, Walther D, Rice KC, Baumann MH.

Addict Biol. 2019 Nov 13:e12842. doi: 10.1111/adb.12842. [Epub ahead of print]

PMID:
31724254
2.

Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Jordan CJ, Humburg BA, Thorndike EB, Shaik AB, Xi ZX, Baumann MH, Newman AH, Schindler CW.

J Pharmacol Exp Ther. 2019 Dec;371(3):602-614. doi: 10.1124/jpet.119.259390. Epub 2019 Sep 27.

3.

The Supplement Adulterant β-Methylphenethylamine Increases Blood Pressure by Acting at Peripheral Norepinephrine Transporters.

Schindler CW, Thorndike EB, Rice KC, Partilla JS, Baumann MH.

J Pharmacol Exp Ther. 2019 Jun;369(3):328-336. doi: 10.1124/jpet.118.255976. Epub 2019 Mar 21.

4.

Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.

Schindler CW, Gramling BR, Justinova Z, Thorndike EB, Baumann MH.

Drug Alcohol Depend. 2017 Oct 1;179:387-394. doi: 10.1016/j.drugalcdep.2017.07.029. Epub 2017 Aug 18.

5.

Attenuating Nicotine Reinforcement and Relapse by Enhancing Endogenous Brain Levels of Kynurenic Acid in Rats and Squirrel Monkeys.

Secci ME, Auber A, Panlilio LV, Redhi GH, Thorndike EB, Schindler CW, Schwarcz R, Goldberg SR, Justinova Z.

Neuropsychopharmacology. 2017 Jul;42(8):1619-1629. doi: 10.1038/npp.2017.21. Epub 2017 Jan 31.

6.

Pharmacological mechanisms underlying the cardiovascular effects of the "bath salt" constituent 3,4-methylenedioxypyrovalerone (MDPV).

Schindler CW, Thorndike EB, Suzuki M, Rice KC, Baumann MH.

Br J Pharmacol. 2016 Dec;173(24):3492-3501. doi: 10.1111/bph.13640. Epub 2016 Nov 16.

7.

Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.

Panlilio LV, Thorndike EB, Nikas SP, Alapafuja SO, Bandiera T, Cravatt BF, Makriyannis A, Piomelli D, Goldberg SR, Justinova Z.

Psychopharmacology (Berl). 2016 May;233(10):1879-88. doi: 10.1007/s00213-015-4140-6. Epub 2015 Nov 12.

8.

Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.

Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD, Baumann MH.

Psychopharmacology (Berl). 2016 May;233(10):1981-90. doi: 10.1007/s00213-015-4057-0. Epub 2015 Aug 29.

9.

Persistent palatable food preference in rats with a history of limited and extended access to methamphetamine self-administration.

Caprioli D, Zeric T, Thorndike EB, Venniro M.

Addict Biol. 2015 Sep;20(5):913-26. doi: 10.1111/adb.12220. Epub 2015 Jan 12.

10.

Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.

Schindler CW, Thorndike EB, Blough BE, Tella SR, Goldberg SR, Baumann MH.

Br J Pharmacol. 2014 Jan;171(1):83-91. doi: 10.1111/bph.12423.

11.

Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW.

Neuropsychopharmacology. 2013 Mar;38(4):552-62. doi: 10.1038/npp.2012.204. Epub 2012 Oct 17.

12.

Combined effects of THC and caffeine on working memory in rats.

Panlilio LV, Ferré S, Yasar S, Thorndike EB, Schindler CW, Goldberg SR.

Br J Pharmacol. 2012 Apr;165(8):2529-38. doi: 10.1111/j.1476-5381.2011.01554.x.

13.

Rapid delivery of cocaine facilitates acquisition of self-administration in rats: an effect masked by paired stimuli.

Schindler CW, Cogan ES, Thorndike EB, Panlilio LV.

Pharmacol Biochem Behav. 2011 Sep;99(3):301-6. doi: 10.1016/j.pbb.2011.05.005. Epub 2011 May 11.

14.

Automatic recording of mediating behavior in delayed matching- and nonmatching-to-position procedures in rats.

Panlilio LV, Yasar S, Thorndike EB, Goldberg SR, Schindler CW.

Psychopharmacology (Berl). 2011 Mar;214(2):495-504. doi: 10.1007/s00213-010-2057-7. Epub 2010 Nov 18.

15.

Effect of rate of delivery of intravenous cocaine on self-administration in rats.

Schindler CW, Panlilio LV, Thorndike EB.

Pharmacol Biochem Behav. 2009 Oct;93(4):375-81. doi: 10.1016/j.pbb.2009.05.008. Epub 2009 May 21.

16.

A stimulus-control account of dysregulated drug intake.

Panlilio LV, Thorndike EB, Schindler CW.

Pharmacol Biochem Behav. 2009 May;92(3):439-47. doi: 10.1016/j.pbb.2009.01.011. Epub 2009 Jan 24.

17.

A stimulus-control account of regulated drug intake in rats.

Panlilio LV, Thorndike EB, Schindler CW.

Psychopharmacology (Berl). 2008 Feb;196(3):441-50. Epub 2007 Oct 24.

18.

Differential involvement of dopamine receptors in conditioned suppression induced by cocaine.

Grakalic I, Panlilio LV, Thorndike EB, Schindler CW.

Eur J Pharmacol. 2007 Nov 14;573(1-3):116-23. Epub 2007 Jun 30.

19.
20.

Cocaine self-administration under variable-dose schedules in squirrel monkeys.

Panlilio LV, Thorndike EB, Schindler CW.

Pharmacol Biochem Behav. 2006 Jun;84(2):235-43. Epub 2006 Jun 30.

PMID:
16814853
21.

Lorazepam reinstates punishment-suppressed remifentanil self-administration in rats.

Panlilio LV, Thorndike EB, Schindler CW.

Psychopharmacology (Berl). 2005 May;179(2):374-82. Epub 2004 Oct 27.

PMID:
15821953
22.

Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.

Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Ferré S, Goldberg SR.

Br J Pharmacol. 2005 Mar;144(5):642-50.

23.

Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680.

Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Goldberg SR, Ferré S.

Eur J Pharmacol. 2004 Jan 26;484(2-3):269-75.

PMID:
14744613
24.

Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats.

Jun JH, Thorndike EB, Schindler CW.

Psychopharmacology (Berl). 2004 Mar;172(3):277-82. Epub 2003 Nov 21.

PMID:
14634714
25.

Reinstatement of punishment-suppressed opioid self-administration in rats: an alternative model of relapse to drug abuse.

Panlilio LV, Thorndike EB, Schindler CW.

Psychopharmacology (Berl). 2003 Jul;168(1-2):229-235. doi: 10.1007/s00213-002-1193-0. Epub 2002 Aug 9.

PMID:
12845420
26.

Gender differences in the behavioral effects of methamphetamine.

Schindler CW, Bross JG, Thorndike EB.

Eur J Pharmacol. 2002 May 10;442(3):231-5.

PMID:
12065076
27.

Conditioned suppression with cocaine as the unconditioned stimulus.

Schindler CW, Thorndike EB, Ma JD, Goldberg SR.

Pharmacol Biochem Behav. 2000 Jan 1;65(1):83-9.

PMID:
10638640
28.

GABA receptor-linked chloride channels and the behavioral effects of naltrexone in rats.

Gewiss MV, Marley RJ, Thorndike EB, Goldberg SR, Schindler CW.

Pharmacol Biochem Behav. 1994 Nov;49(3):589-97.

PMID:
7862713
29.

Evaluation of deprenyl for cocaine-like discriminative stimulus effects in rats.

Yasar S, Schindler CW, Thorndike EB, Goldberg SR.

Eur J Pharmacol. 1994 Jul 11;259(3):243-50.

PMID:
7982450
30.

Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.

Yasar S, Schindler CW, Thorndike EB, Szelenyi I, Goldberg SR.

J Pharmacol Exp Ther. 1993 Apr;265(1):1-6.

PMID:
8473997

Supplemental Content

Loading ...
Support Center